# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001714899-26-000055
Filing Date
2026-04-21
Accepted
2026-04-21 16:32:48
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | fy25denalitherapeuticsannu.pdf | ARS | 19614229
| Complete submission text file | 0001714899-26-000055.txt |  | 26858899

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38311 | Film No.: 26879980
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)